Company: PETVW
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001493152-25-011967
Chunk: 42

Company: PetVivo Holdings, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 42
---
IDITY
AND CAPITAL RESOURCES

As
of June 30, 2025, our current assets were $4,400,859, including $3,303,844 in cash and cash equivalents. In comparison, our current liabilities
as of that date were $3,117,433 including $1,590,770 of accounts payable and accrued expenses. Our working capital as of June 30, 2025
was $1,283,426.

The
Company has continued to realize losses from operations. As a result of our private placement offering with proceeds of $5,000,000 from
the sale of Series B convertible preferred stock, we do not believe we will have sufficient cash to meet our anticipated operating costs
and capital expenditure requirements for at least the next twelve months. We will need to raise additional capital in the future to support
our efforts to commercialize Spryng® and our ongoing operations. We expect to continue to raise additional capital through
the sale of our securities from time to time for the foreseeable future to fund our business expansion. Our ability to obtain such additional
capital will likely be subject to various factors, including our overall business performance and market conditions. There can be no
guarantee that the Company will be successful in its ability to raise additional capital to fund its business plan.

Net
Cash Used in Operating Activities – We used $1,633,755 of net cash in operating activities for the three months ended June
30, 2025. This cash used in operating activities was primarily attributable to our net loss of $2,311,037 and the extinguishment of derivative
liability of $768,493, and an unrealized loss on change in fair value of derivatives
of $320,404.

Net
Cash Used in Investing Activities – During the three months ended June 30, 2025, net cash used in investing activities was $0.

Net
Cash Provided by Financing Activities – During the three months ended June 30, 2025, net cash provided by financing activities of $4,709,910 consisted
of proceeds of Series B preferred stock receivable of $4,400,000, proceeds from the issuance of convertible debentures of $160,000 and
proceeds from the exercise of a warrant of $140,000.

28

MATERIAL
COMMITMENTS

Notes
Payable

As
of June 30, 2025, we are obligated on non-convertible notes and accrued interest